Literature DB >> 16377708

Anucleate cell blue assay: a useful tool for identifying novel type II topoisomerase inhibitors.

Yoshihiro Oyamada1, Hideaki Ito, Mika Fujimoto-Nakamura, Akihiko Tanitame, Noritaka Iwai, Kazuo Nagai, Jun-Ichi Yamagishi, Masaaki Wachi.   

Abstract

About 95,000 compounds were screened by the anucleate cell blue assay. Fifty-one of the hit compounds had various structures and showed inhibitory activity against DNA gyrase and/or topoisomerase IV. Moreover, the compounds exhibited antibacterial activity against a fluoroquinolone- and novobiocin-resistant strain of Staphylococcus aureus. The anucleate cell blue assay is therefore a useful tool for finding novel type II topoisomerase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16377708      PMCID: PMC1346804          DOI: 10.1128/AAC.50.1.348-350.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays.

Authors:  A B Khodursky; B J Peter; M B Schmid; J DeRisi; D Botstein; P O Brown; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Chromosome partitioning in Escherichia coli: novel mutants producing anucleate cells.

Authors:  S Hiraga; H Niki; T Ogura; C Ichinose; H Mori; B Ezaki; A Jaffé
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

3.  DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex.

Authors:  H Hiasa; D O Yousef; K J Marians
Journal:  J Biol Chem       Date:  1996-10-18       Impact factor: 5.157

4.  Inhibition of deoxyribonucleic acid gyrase: effects on nucleic acid synthesis and cell division in Escherichia coli K-12.

Authors:  N F Fairweather; E Orr; I B Holland
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

5.  Irregular nuclear localization and anucleate cell production in Escherichia coli induced by a Ca2+ chelator, EGTA.

Authors:  M Wachi; N Iwai; A Kunihisa; K Nagai
Journal:  Biochimie       Date:  1999 Aug-Sep       Impact factor: 4.079

6.  Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.

Authors:  K Sato; Y Inoue; T Fujii; H Aoyama; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.

Authors:  J Yamagishi; T Kojima; Y Oyamada; K Fujimoto; H Hattori; S Nakamura; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

8.  Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.

Authors:  Mika Fujimoto-Nakamura; Hideaki Ito; Yoshihiro Oyamada; Takeshi Nishino; Jun-Ichi Yamagishi
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

9.  Novel S-benzylisothiourea compound that induces spherical cells in Escherichia coli probably by acting on a rod-shape-determining protein(s) other than penicillin-binding protein 2.

Authors:  Noritaka Iwai; Kazuo Nagai; Masaaki Wachi
Journal:  Biosci Biotechnol Biochem       Date:  2002-12       Impact factor: 2.043

10.  The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography.

Authors:  R J Lewis; O M Singh; C V Smith; T Skarzynski; A Maxwell; A J Wonacott; D B Wigley
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

View more
  2 in total

1.  5-Alkyloxytryptamines are membrane-targeting, broad-spectrum antibiotics.

Authors:  Katherine C Faulkner; Katherine A Hurley; Douglas B Weibel
Journal:  Bioorg Med Chem Lett       Date:  2016-10-05       Impact factor: 2.823

Review 2.  A How-To Guide for Mode of Action Analysis of Antimicrobial Peptides.

Authors:  Ann-Britt Schäfer; Michaela Wenzel
Journal:  Front Cell Infect Microbiol       Date:  2020-10-19       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.